fungal infections
Diasorin Nabs CE-IVDR Marking for Candida auris PCR Assay
The Simplexa C. auris Direct kit is a real-time PCR assay that is used for the detection of DNA from six clades of the fungal pathogen in patients with suspected colonization.
The company aims to soon launch two tests to aid the treatment of dermatomycosis and is developing other tests for healthcare-acquired infections and lung diseases.
Investigators found that they could increase CNS infection diagnoses by using metagenomic next-generation sequencing to test cerebrospinal fluid samples.
Diagnostics firm QuantaMatrix plans to commercialize the technologies with an automated instrument for pathogen detection, identification, and resistance profiling.
Diasorin Nabs FDA De Novo Clearance for Candida Auris Assay
The firm said that the test can be used to help prevent and control the spread of the fungal pathogen, which is a common cause of hospital-acquired infections.